verapamil/trandolapril overdose

1
Reactions 1164 - 11 Aug 2007 O S Verapamil/trandolapril overdose Death: case report A 57-year-old woman died after ingestion of an inadvertent overdose of verapamil/trandolapril tablets for hypertension. The woman, whose history included diabetes mellitus with mild chronic renal failure, received a 7-pill sample pack of a once-daily verapamil/trandolapril 240mg/2mg combination product [Tarka]. She was confused about what dosage to take and was witnessed ingesting three pills at once, 2 days later. She was doing well for several hours but was found unresponsive on her couch a further 12 hours later. Four tablets were missing from the packet, but the time of the ingestion of the fourth tablet was unknown. About 48 hours after the woman’s death, an autopsy revealed mild myocardial fibrosis, bilateral pulmonary oedema, mild to moderate atherosclerosis of the coronary arteries, aorta and cerebral vessels, chronic pyelonephritis and renal arteriosclerosis. A lethal verapamil concentration of 6 mg/L as well as a verapamil metabolite were detected in her heart blood. Peripheral blood could not be obtained and no testing for trandolapril concentrations was available. Author comment: "[T]he decedent’s preexisting medical conditions likely contributed to her death. As verapamil is mainly excreted by the kidneys, any acute or chronic renal insufficiency may lead to decreased clearance of the drug. . . Furthermore, the myocyte hypertrophy and interstitial fibrosis seen in the heart possibly played a role in the death. The likely mechanism of death in verapamil overdoses is heart failure due to decreased myocardial contractility and/or complete heart block." Batalis NI, et al. Verapamil toxicity - an unusual case report and review of the literature. American Journal of Forensic Medicine and Pathology 28: 137-140, No. 2, Jun 2007 - USA 801094404 1 Reactions 11 Aug 2007 No. 1164 0114-9954/10/1164-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: vannga

Post on 16-Mar-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Verapamil/trandolapril overdose

Reactions 1164 - 11 Aug 2007

O SVerapamil/trandolapril overdose

Death: case reportA 57-year-old woman died after ingestion of an inadvertent

overdose of verapamil/trandolapril tablets for hypertension.The woman, whose history included diabetes mellitus with

mild chronic renal failure, received a 7-pill sample pack of aonce-daily verapamil/trandolapril 240mg/2mg combinationproduct [Tarka]. She was confused about what dosage to takeand was witnessed ingesting three pills at once, 2 days later.She was doing well for several hours but was foundunresponsive on her couch a further 12 hours later. Fourtablets were missing from the packet, but the time of theingestion of the fourth tablet was unknown.

About 48 hours after the woman’s death, an autopsyrevealed mild myocardial fibrosis, bilateral pulmonaryoedema, mild to moderate atherosclerosis of the coronaryarteries, aorta and cerebral vessels, chronic pyelonephritis andrenal arteriosclerosis. A lethal verapamil concentration of6 mg/L as well as a verapamil metabolite were detected in herheart blood. Peripheral blood could not be obtained and notesting for trandolapril concentrations was available.

Author comment: "[T]he decedent’s preexisting medicalconditions likely contributed to her death. As verapamil ismainly excreted by the kidneys, any acute or chronic renalinsufficiency may lead to decreased clearance of thedrug. . . Furthermore, the myocyte hypertrophy andinterstitial fibrosis seen in the heart possibly played a role inthe death. The likely mechanism of death in verapamiloverdoses is heart failure due to decreased myocardialcontractility and/or complete heart block."Batalis NI, et al. Verapamil toxicity - an unusual case report and review of theliterature. American Journal of Forensic Medicine and Pathology 28: 137-140, No.2, Jun 2007 - USA 801094404

1

Reactions 11 Aug 2007 No. 11640114-9954/10/1164-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved